STAMBP and Chronic colitis: In a murine model of acute and chronic colitis, twice-daily α-MSH exposure was associated with an 80% reduction in fecal blood, reduced weight loss, and reduced TNF-α in the lower colon and nitric oxide production in the lower bowel (16).